Spectral AI (MDAI) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$15.4M

Revenue (quarter)

$3.5M

Revenue growth (year over year)

−30.42%

Gross profit (trailing twelve months)

$6.6M

Gross margin

42.92%

Net income (trailing twelve months)

−$10.1M

Net income (quarter)

−$4.2M

Net income growth (year over year)

+47.59%

Net margin

−65.54%

Return on equity

—

EPS (trailing twelve months)

−$0.32

Book value per share

−$0.37

P/E (trailing twelve months)

—

Price to book

—

Debt to assets

162.02%

Payout ratio

—

Dividend yield

—

Company profile

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

• Is Spectral AI (MDAI) profitable?

  No. Spectral AI reported a net loss of $10.1M over the trailing twelve months.

• How much revenue does Spectral AI (MDAI) make?

  Spectral AI generated $15.4M in revenue over the trailing twelve months, down 30.42% year over year.

• How do I buy stock in Spectral AI (MDAI)?

  MDAI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.